The global injectable drug delivery devices market size is expected to expand at a healthy CAGR during the forecast period, 2021-2028. The growth of the market is attributed to growing prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes. Moreover, rising use of disposable syringes due to rising burden of chronic diseases is driving the market growth.
A major number of drugs and therapies that address these chronic ailments are available. However, the use of syringes in the management of any chronic ailment is inevitable. Syringes can either be a part of sample collection during diagnosis or treatment regimen such as osteoarthritis.
Market Drivers, Restraints, Trends, and Opportunities
- Rising technological advancements and improving patient compliance are expected to propel the market growth.
- Beneficial reimbursement policies and rising number of biologics in the pharmaceutical market are anticipated to spur the growth of the market.
- The advantages of self-injectable injections and increasing awareness about self-administration are speculated to proliferate the market growth.
- The COVID-19 outbreak has encouraged pharmaceutical companies to develop vaccines, which in turn, has created lucrative opportunities during the forecast period.
Scope of the Injectable Drug Delivery Devices Market Report
The report on the injectable drug delivery devices market includes an assessment of the market, trends, segments and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Injectable Drug Delivery Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Types (Conventional Drug Delivery Devices and Advanced Drug Delivery Devices (Prefilled Syringes, Injectable Pens, Auto Injectors, Needle-free Injectors, Other Device Types), Therapeutic Applications (Cardiovascular Diseases, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Baxter International Inc., Becton, Dickinson and Company, Gerresheimer AG, Teva Pharmaceutical Industries Ltd, and Eli Lilly and Company
|
Injectable Drug Delivery Devices Market Segment Insights
Self-injectable drug delivery devices segment to account a large market share
Based on types, the market is divided into conventional drug delivery devices, self-injectable drug delivery devices, and advanced drug delivery devices.
The advanced drug delivery devices segment is further segmented into prefilled syringes, injectable pens, auto injectors, needle-free injectors, and others. The self-Injectable drug delivery devices segment is projected to account for a large market share during the forecast period. Rising number of diabetes patient is expected to propel the segment growth. Self-injectable devices are convenient to use and are inexpensive in nature. Rising innovation in self-injectable devices is expected to further boost the segment growth.
Diabetes segment to exhibit a high CAGR
On the basis of therapeutic applications, the market is classified as cardiovascular diseases, diabetes, oncology, autoimmune disorders, hepatitis, and others.
The diabetes segment is projected to expand at a high CAGR during the forecast period. Rising prevalence of diabetes is driving the market segment growth. Diabetes is one of the most common diseases around the world. Many people use insulin injections to cope with the disease. Hence, the demand for injectable drug delivery devices is growing at a healthy rate in the market.
North America to account a considerable market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to account for a considerable market share during the forecast period. The segment growth is attributed to the increasing geriatric population and rising incidence of chronic diseases in the countries such as the US and Canada. Increasing healthcare expenditure, rising focus on health, and growing government funding are expected to foster the regional market growth.
Segments
The global injectable drug delivery devices market has been segmented on the basis of:
Type
- Conventional Drug Delivery Devices
- Self-injectable Drug Delivery Devices
- Advanced Drug Delivery Devices
- Prefilled Syringes
- Injectable Pens
- Auto Injectors
- Needle-free Injectors
- Others
Therapeutic Applications
- Cardiovascular Diseases
- Diabetes
- Oncology
- Autoimmune Disorders
- Hepatitis
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key players
Competitive Landscape
Some of the major players in the market are Baxter International Inc., Becton, Dickinson and Company, Gerresheimer AG, Teva Pharmaceutical Industries Ltd, and Eli Lilly and Company.
The companies operating in the market are focusing on product innovation, expansion, and exploring new markets. Moreover, they’re partnering with local manufacturers to expand their market share.
Request For Customization
Enquiry Before Buying
Speak With Analyst
